Company / Return on Equity (ROE)
LifeMD, Inc. Return on Equity (ROE) History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Equity (ROE)
-92.5%
FY2025
5-year range
-1299.0% / -92.5%
FY2021-FY2025
Trend
-
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
LifeMD, Inc. reports negative total equity of -92.5% in FY2025. Negative equity can occur when accumulated losses exceed contributed capital, as reported in the balance sheet from the SEC filing.
Based on SEC 10-K filings.
-92.5% in FY2025.
Improved from -257.9% to -92.5% over the past 4 years.
Return on Equity (ROE) over time
Growth rates
- 3-Year Change
- -
- 5-Year Change
- -
- 10-Year Change
- -
Key checks
Key Insights
- Peak return on equity (roe) was recorded in FY2016.
- Lowest return on equity (roe) in the period was in FY2023.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Equity (ROE)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -92.5% | - |
| FY2024 | - | - |
| FY2023 | -1299.0% | - |
| FY2022 | - | - |
| FY2021 | -257.9% | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | -134.3% | -7.0% |
| FY2017 | -125.6% | -102.7% |
| FY2016 | -61.9% | +86.5% |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026